Los puntos clave no están disponibles para este artículo en este momento.
Abstract With the adoption of the Foreign State Immunity Law in September 2023, China officially switches from absolute State immunity to restrictive State immunity. This paper analyses selected provisions of the new law which are likely to cause problems in practice. In addition, the paper also reflects upon the marginal position of Chinese courts in immunity cases in the past and the implication of the new law under the principle of “One Country, Two Systems”.
Xinxiang Shi (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: